226 related articles for article (PubMed ID: 8833624)
41. Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.
Clifford GM; Rickenbach M; Polesel J; Dal Maso L; Steffen I; Ledergerber B; Rauch A; Probst-Hensch NM; Bouchardy C; Levi F; Franceschi S;
AIDS; 2008 Oct; 22(16):2135-41. PubMed ID: 18832877
[TBL] [Abstract][Full Text] [Related]
42. [Diffusion of hepatitis B among residents of an institution for handicapped children].
Arnedo Pena A; Latorre Ibáñez MD; Cortés Edo JM; Pac Sa MR; Querol Sanjuán J; González Morán F; Safont Adsuara L; Hernández Martín R
Rev Esp Salud Publica; 1995; 69(2):219-26. PubMed ID: 7497347
[TBL] [Abstract][Full Text] [Related]
43. Fulminant hepatic failure during remission from leukemia: three cases associated with massive liver cell necrosis and hepatitis B virus.
Watanabe A; Higashi T; Endo H; Nagashima H
Acta Med Okayama; 1979 Aug; 33(4):245-57. PubMed ID: 158950
[TBL] [Abstract][Full Text] [Related]
44. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.
Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH
Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842
[No Abstract] [Full Text] [Related]
45. High prevalence of human T-lymphotropic virus type I carriers among patients with myelodysplastic syndrome refractory anemia with excess of blasts (RAEB), RAEB in transformation and acute promyelocytic leukemia.
Inoue H; Matsushita K; Arima N; Hamada H; Uozumi K; Ozaki A; Akimoto M; Kawada H; Kukita T; Yoshimitsu M; Matsumoto T; Tei C
Leuk Lymphoma; 2008 Feb; 49(2):315-21. PubMed ID: 18231919
[TBL] [Abstract][Full Text] [Related]
46. [Laboratory tests in Japanese Red Cross Blood Centers to prevent transfusion-transmitted diseases].
Watanabe J
Rinsho Byori; 1991 Mar; Suppl 88():60-9. PubMed ID: 1906951
[No Abstract] [Full Text] [Related]
47. Prevalence of hepatitis B markers in occupational health nurses.
Strickler AC; Bradshaw ED
J Occup Med; 1987 Aug; 29(8):685-7. PubMed ID: 3655952
[TBL] [Abstract][Full Text] [Related]
48. Light microscopic localization of hepatitis B virus antigens in the human pancreas. Possibility of multiplication of hepatitis B virus in the human pancreas.
Shimoda T; Shikata T; Karasawa T; Tsukagoshi S; Yoshimura M; Sakurai I
Gastroenterology; 1981 Dec; 81(6):998-1005. PubMed ID: 6169587
[TBL] [Abstract][Full Text] [Related]
49. [Ausria/Core. Simultaneous detection of hepatitis B virus core surface antigen and antibody using 3rd generation tests].
Kselíková M; Urbánková J
Radiobiol Radiother (Berl); 1984; 25(5):783-4. PubMed ID: 6505196
[No Abstract] [Full Text] [Related]
50. [Detection of HTLV-I virus in patients with myeloproliferative hemoblastoses].
Kukaĭn RA; Murovska MF; Mullere IV; Vinkele RA; Tkachenko TI; Ose VP; Pashkute MK; Kalnberza GK; Grasmane DV; Teĭlane II
Vopr Onkol; 1993; 39(1-3):44-9. PubMed ID: 8073675
[TBL] [Abstract][Full Text] [Related]
51. Human T-cell leukemia virus type I infection as an oncogenic and prognostic risk factor in cervical and vaginal carcinoma.
Miyazaki K; Yamaguchi K; Tohya T; Ohba T; Takatsuki K; Okamura H
Obstet Gynecol; 1991 Jan; 77(1):107-10. PubMed ID: 1984208
[TBL] [Abstract][Full Text] [Related]
52. [Identification of HTLV-I markers in patients with hemoblastoses].
Kukaĭn RA; Nagaeva LI; Kalnberza IV; Murovska MF; Vinkele RA; Oss VP; Tkachenko TIu
Vopr Onkol; 1990; 36(1):40-5. PubMed ID: 2305561
[TBL] [Abstract][Full Text] [Related]
53. A seroepidemiologic survey of human T-cell lymphotropic virus type I in two Hawaiian hematologic-oncologic practices.
Kimata JT; Kaneshiro SA; Kwock DW; Nakamura S; Kaneshiro MM; Nakamura JM
West J Med; 1989 Mar; 150(3):300-2. PubMed ID: 2735036
[TBL] [Abstract][Full Text] [Related]
54. Clinical features of HTLV-I associated uveitis determined in multicenter collaborative study. Study Group for HTLV-I Associated Ocular Diseases.
Ohba N; Nakao K; Isashiki Y; Kaminagayoshi T; Sonoda S; Yashiki S; Osame M
Jpn J Ophthalmol; 1994; 38(2):168-74. PubMed ID: 7967208
[TBL] [Abstract][Full Text] [Related]
55. Radioimmunoassays of hidden viral antigens.
Neurath AR; Strick N; Baker L; Krugman S
Dev Biol Stand; 1983; 54():143-50. PubMed ID: 6653886
[TBL] [Abstract][Full Text] [Related]
56. A morphological pattern of 234 cases of leukemias.
Hassan K; Ikram N; Shah SH
J Pak Med Assoc; 1994 Jun; 44(6):145-8. PubMed ID: 8089909
[TBL] [Abstract][Full Text] [Related]
57. [Clinical aspects of severe forms of serum hepatitis type B].
Ketiladze ES; Farber NA; Zhilina NN; Vorozhbieva TE; Savitskiĭ GI
Klin Med (Mosk); 1980 Jan; 58(1):46-52. PubMed ID: 6966013
[No Abstract] [Full Text] [Related]
58. Hepatitis B surface antigenaemia in patients with malignant lymphoproliferative disorders.
Olatunji PO; Okpala IE; Sorunmu MA
Tokai J Exp Clin Med; 1991 Oct; 16(3-4):171-3. PubMed ID: 1811350
[TBL] [Abstract][Full Text] [Related]
59. Epidemiology of acute promyelocytic leukemia.
Mele A; Stazi MA; Pulsoni A; Visani G; Monarca B; Castelli G; Rocchi L; Avvisati G; Mandelli F
Haematologica; 1995; 80(5):405-8. PubMed ID: 8566879
[TBL] [Abstract][Full Text] [Related]
60. [Hepatitis B virus hazard of dentists and dental assistants].
Scheiermann N; Kuwert EK; Engelhardt JP
Dtsch Zahnarztl Z; 1981 Oct; 36(10):614-8. PubMed ID: 6947875
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
